IMPLEMENTATION OF A NEW VERSION OF THE OsSC PLATFORM FOR THE SUBMISSION OF CTAs AND AMENDMENTS IN ITALY

Changes in the management of Clinical Trial Applications and amendments have recently been introduced in Italy. A new version of…

READ

BREXIT- ARE YOU FULFILLING YOUR TASKS?

Further to the Brexit, all Union laws cease to apply to the United Kingdom from 30th March 2019. The “transition…

READ

AIFA – ANNUAL FEE 2017: UPCOMING DEADLINE FOR PAYMENT (JULY 31ST, 2018)

We are getting close to the deadline relevant to the payment of the annual fee due to AIFA. Every year,…

READ

SERIALIZATION: COMMISSION DELEGATED REGULATION (EU) 2016/161

According to the Commission Delegated Regulation (EU) No 2016/161, new measures for the control of medicinal products in Europe have…

READ

PROMOTIONAL MATERIAL: NEW SUBMISISON PROCEDURE IN ITALY

In Italy, a new submission procedure for the promotional material addressed to healthcare professionals has come into force on June…

READ

Elemental Impurities: risk-based control strategy

The guideline ICH Q3D – GUIDELINE FOR ELEMENTAL IMPURITIES, which is now fully into force (effective for new marketing authorization…

READ

MEDICAL DEVICES – EUROPEAN REGULATION 2017/745: THE PERSON RESPONSIBLE FOR REGULATORY COMPLIANCE

The European regulation 2017/745 of medical devices will become effective in May 2020 and manufactures, authorized representatives, distributors and all…

READ

NEW LEGISLATION ABOUT COMPASSIONATE USE IN ITALY

The new legislation about “Discipline of the therapeutic use of an investigational medicinal product” (Ministerial Decree September 7, 2017) which…

READ

NEW EUDRAVIGILANCE VERSION: IMPACT ON THE ITALIAN PV SYSTEM

On November 22nd, 2017 EMA will launch a new and improved version of EudraVigilance. This will have impact also to…

READ

REGULATORY PHARMA NET EXHIBITS AT ISPOR 20TH Annual European Congress

RPN will exhibit at ISPOR 20TH Annual European Congress that will be held at the Scottish Event Campus (SEC), Glasgow, Scotland  4-8…

READ